The EGFR Test is a type of In Vitro Diagnostics (IVD) used to detect the presence of epidermal growth factor receptor (EGFR) mutations in a patient's tumor. It is used to help diagnose and treat certain types of cancer, such as non-small cell lung cancer. The test is typically performed on a sample of tissue taken from the patient's tumor. The results of the test can help doctors determine the best course of treatment for the patient. The EGFR Test market is a subset of the larger IVD market, which is estimated to be worth billions of dollars. The EGFR Test market is expected to grow in the coming years due to the increasing prevalence of cancer and the need for more accurate and personalized treatments. Some of the major players in the EGFR Test market include Roche, Abbott, Qiagen, Thermo Fisher Scientific, and Agilent Technologies. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
